• rTMS Drives Cognitive Recovery via GABAergic Modulation in A

  2026-06-19

  This study elucidates how repetitive transcranial magnetic stimulation (rTMS) enhances cognitive recovery in Alzheimer's disease models by activating GABAergic neurons and upregulating the Cx3cl1-Cx3cr1 axis. The findings provide mechanistic insight into non-invasive AD therapies and highlight new targets for translational research.

• Hydroxychloroquine Sulfate: Technical Guidance for Autoimmun

  2026-06-19

  Hydroxychloroquine Sulfate is a synthetic quinoline derivative used to inhibit autophagy and TLR7/9 signaling in autoimmune disease research, particularly for systemic lupus erythematosus and rheumatoid arthritis. This compound is best suited for aqueous-based, short-term protocols and is not recommended where organic solvent solubility or long-term solution storage are required.

• HDAC Inhibitors Suppress NUT Function in NUT Carcinoma Cells

  2026-06-18

  Shiota et al. conducted a high-throughput chemical screen and identified diverse histone deacetylase (HDAC) inhibitors as potent repressors of NUT-mediated transcriptional activation in NUT carcinoma cells. These findings illuminate critical epigenetic mechanisms underlying NUT carcinoma pathogenesis and highlight HDAC inhibition as a promising therapeutic strategy.

• MK-1775: Applied Workflows for Wee1 Kinase Inhibitor Researc

  2026-06-18

  MK-1775 (Wee1 kinase inhibitor) stands out for its nanomolar potency and high selectivity, enabling precise abrogation of the G2 DNA damage checkpoint in p53-deficient cancer models. This article distills evidence-based workflows, actionable troubleshooting, and translational best practices to help researchers unlock advanced applications and maximize the impact of MK-1775 in contemporary cancer studies.

• Streptavidin-HyperFluor 647: Shaping the Future of Translati

  2026-06-17

  This thought-leadership article explores how Streptavidin-HyperFluor™ 647 is redefining biotinylated target detection for translational researchers. It blends mechanistic insights, strategic guidance, and competitive analysis, with evidence-backed discussion of innovative proximity labeling workflows, including biotin-dependent and biotin-free systems, and practical protocol considerations. The piece highlights APExBIO’s product edge and outlines the future trajectory of sensitive proteomic mapping.

• Precision Tools for Translational Gene Expression Analysis

  2026-06-17

  This article explores how mechanistically advanced SYBR Green qPCR master mixes, particularly the HotStart™ 2X Green qPCR Master Mix from APExBIO, are revolutionizing real-time PCR gene expression analysis in translational research. Building on new findings in adipocyte epigenetics, we examine how antibody-mediated Taq polymerase hot-start inhibition enhances data fidelity, empowers RNA-seq validation, and closes the gap between molecular discovery and clinical application.

• Tioconazole in Antifungal Drug Development: Applied Protocol

  2026-06-16

  Tioconazole stands out as a high-purity antifungal agent, enabling robust in vitro and in vivo fungal infection models. This guide delivers step-by-step experimental workflows, advanced applications, and evidence-driven troubleshooting strategies to maximize research reproducibility and discovery impact.

• Caspase-3 Fluorometric Assay Kit: Advancing Apoptosis Insigh

  2026-06-16

  This thought-leadership article explores the mechanistic underpinnings of caspase-3 in apoptosis, analyzes recent oncology findings, and presents strategic guidance for translational researchers. It demonstrates how the APExBIO Caspase-3 Fluorometric Assay Kit is redefining apoptosis assay precision and reliability, integrating evidence from peer-reviewed studies and current competitive technologies. The article uniquely bridges mechanistic detail with workflow strategy, offering a forward-looking perspective for the apoptosis research community.

• PF-562271 HCl: Redefining FAK/Pyk2 Inhibition for Tumor Immu

  2026-06-15

  Explore how PF-562271 HCl, a potent FAK/Pyk2 inhibitor, enables advanced cancer research by linking kinase inhibition to immune memory and abscopal effects. This article uniquely bridges molecular mechanism with translational assay design.

• Oteseconazole (VT-1161): Advanced Antifungal Assay Strategie

  2026-06-15

  Oteseconazole (VT-1161) delivers unmatched selectivity and potency for bench scientists targeting Candida infections, including fluconazole-resistant strains. Learn how to implement robust workflows, optimize protocols, and troubleshoot challenges for high-impact antifungal research.

• ω-Agatoxin IVA TFA: Structural Selectivity and Translational

  2026-06-14

  Explore how ω-Agatoxin IVA TFA, a potent P/Q-type calcium channel blocker, enables precise neurophysiology and epilepsy research through structural selectivity and translational neuroprotection. This article uniquely connects cryo-EM insights to practical assay and animal model design.

• Ceruletide Models Chronic Pancreatitis: Bridging Mechanism a

  2026-06-13

  This thought-leadership article dissects how Ceruletide (Caerulein) enables precision modeling of pancreatic fibrosis and gastrointestinal physiology, linking mechanistic insights from the MFGE8-ANXA1-SMAD2/3 axis to translational strategy. It provides protocol guidance, competitive landscape analysis, and a forward-looking perspective for researchers seeking to drive innovation in pancreatic function research. APExBIO’s Ceruletide is positioned as the benchmark tool, with a critical evaluation of recent advances in stem cell and nanomedicine approaches.

• Plant Exosome-like Nanovesicles Alleviate Testicular Injury

  2026-06-12

  This study demonstrates that exosome-like nanovesicles derived from Cistanche deserticola (CDELNs) can ameliorate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells. The findings highlight the therapeutic potential of plant-derived nanovesicles in protecting male reproductive function and provide mechanistic insight into cross-kingdom miRNA regulation.

• CX-5461: Optimizing RNA Polymerase I Inhibition in Cancer Re

  2026-06-12

  CX-5461, a potent RNA polymerase I inhibitor from APExBIO, empowers translational cancer research by selectively disrupting ribosome biogenesis and inducing senescence and autophagy in tumor cells. This guide distills advanced use-cases, optimized experimental parameters, and troubleshooting strategies for maximizing CX-5461’s impact in solid tumor models and chemoresistance studies.

• Deep Learning Reveals Cardiotoxicity in iPSC-Derived Models

  2026-06-11

  Grafton et al. introduce a deep learning-based high-content screening platform using human iPSC-derived cardiomyocytes to rapidly detect drug-induced cardiotoxicity. This approach enables early identification of compounds with adverse cardiac effects, improving risk assessment in preclinical drug discovery.

451 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page